Chen Qian, Yi Danhui, Xie Yanming, Yang Wei, Yang Wei, Zhuang Yan, Du Jing
School of Statistics, Renmin University of China, Beijing 100872, China.
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2817-20.
To know how Danhong injection is used in clinical practice and to provide a reference for guiding clinical use of Danhong Injection.
Extract Danhong injection's post-marketing re-evaluation data from the Hospital Information System of ten three grade III-A General Hospitals in Beijing, use basic statistical analysis methods to analyze Danhong injection's indications, usage and dosage, days of treatment etc. in clinical practice.
In patients using Danhong injection, there were more than 60 percent patients were prescribed based on main-diagnosis, first-visit and other diagnosis, which were also coincided with Danhong injection's instruction. In clinical practice, 95.5 percent of Danhong injection's administration routes conformed to the instruction and more than 90 percent of Danhong injection's dosage were within the limits prescribed by the instruction. Danhong injection was used less than 20 days successively. Danhong injection was used in combination with drugs with the action of removing blood stasis, antianginal drug, antiplatelet drug, drugs for cerebrovascular disease and so on.
Danhong injection has been used according to instruction in practice almostly.
了解丹红注射液在临床中的使用情况，为指导丹红注射液的临床应用提供参考。
从北京十家三级甲等综合医院的医院信息系统中提取丹红注射液的上市后再评价数据，采用基本统计分析方法分析丹红注射液在临床实践中的适应证、用法用量、治疗天数等。
在使用丹红注射液的患者中，60%以上的患者是根据主要诊断、初诊及其他诊断开具的处方，这也与丹红注射液的说明书相符。在临床实践中，95.5%的丹红注射液给药途径符合说明书要求，90%以上的丹红注射液用量在说明书规定的范围内。丹红注射液连续使用少于20天。丹红注射液与活血化瘀药、抗心绞痛药、抗血小板药、脑血管病用药等联合使用。
丹红注射液在实际应用中基本按照说明书使用。
